window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biotech

  • Biotech,Funding,Immunology,Oncology,Research & Development

    Laigo Bio raises €17m seed funding to advance oncology pipeline

    Laigo Bio has completed a €17 million seed financing round [...]

    March 23, 2026
  • Biotech,CDMOs & Manufacturing,Clinical Trials,Funding,Healthcare leadership,Oncology

    Mestag Therapeutics raises $40M and adds leadership ahead of cancer trial

    Mestag Therapeutics has raised $40 million and appointed two senior [...]

    March 23, 2026
  • Biotech,Clinical Trials,FDA,Hematology,Rare Diseases,Regulatory Affairs

    Hemab Therapeutics wins FDA breakthrough therapy status for sutacimig in Glanzmann thrombasthenia

      The FDA has granted breakthrough therapy designation to Hemab [...]

    March 5, 2026
  • Biotech,Cell & Gene Therapy,Drug Development,Oncology,Partnerships & Funding

    Molecular Partners signs development agreement with Eckert & Ziegler for targeted alpha Radio-DARPin therapeutics

    Molecular Partners AG, a clinical-stage biotech developing DARPin-based therapeutics, announced [...]

    February 27, 2026
  • Biotech,Cardiovascular diseases,Cell & Gene Therapy,Genomics and sequencing,Opthalmology,Partnerships & Funding

    Circio presents new in vivo data showing enhanced circVec-AAV gene expression in eye

    Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

    February 27, 2026
  • Biotech,Drug Development,Drug discovery,Oncology

    Promatix shows 50-fold potency in colorectal cancer with PBS293 ADC

    Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

    February 25, 2026
  • Biotech,Clinical Development,Clinical Trials,Drug Development,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    AC Immune doses first participant in Phase 1 trial of NLRP3 inhibitor ACI-19764

    AC Immune has initiated a Phase 1 trial of its [...]

    February 24, 2026
  • Biologics & Biosimilars,Biotech,Drug discovery,European biotech,Healthcare leadership,Movers & Shakers,Opthalmology,Research & Development

    Link Biologics appoints Niall Martin to board as TSG-6 pipeline advances towards clinic

    Link Biologics has appointed Niall Martin to its board as [...]

    February 25, 2026
  • Biotech,Cell & Gene Therapy,Drug Development,Oncology

    etherna intratumoral mRNA/LNP platform advances toward IND studies in non-melanoma skin cancer

    etherna, a biotech company specialising in mRNA and lipid nanoparticle [...]

    February 24, 2026
  • Biotech,Healthcare leadership,Movers & Shakers,Partnerships & Funding,Pharmaceuticals and therapeutics

    Aspargo Labs appoints Sam Backenroth as chief financial officer to strengthen corporate and capital markets leadership

    Aspargo Labs, Inc., a pharmaceutical company commercializing a highly absorbent [...]

    February 20, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board
    Categories: Artificial Intelligence, Biotech, Drug Development, Drug discovery, Research & Development
  • Weite Oldenziel
    Ofichem unifies CDMO and pharmaceutical supply brands under single identity
    Categories: CDMOs & Manufacturing, Supply Chain & Logistics
  • DeepCyte raises $1.5M to advance single-cell AI toxicology platform for drug development
    Categories: Artificial Intelligence, Drug discovery, Funding, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top